Ralitoline

CAS No. 1089085-40-4

Ralitoline( —— )

Catalog No. M34390 CAS No. 1089085-40-4

Ralitoline (Ralitolinum) is an anticonvulsant with anticancer activity and sodium channel blocking activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 198 Get Quote
5MG 304 Get Quote
10MG 456 Get Quote
25MG 723 Get Quote
50MG 994 Get Quote
100MG 1332 Get Quote
500MG 2664 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ralitoline
  • Note
    Research use only, not for human use.
  • Brief Description
    Ralitoline (Ralitolinum) is an anticonvulsant with anticancer activity and sodium channel blocking activity.
  • Description
    Ralitoline (Ralitolinum) is an anticonvulsant with anticancer activity and sodium channel blocking activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    Sodium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1089085-40-4
  • Formula Weight
    296.77
  • Molecular Formula
    C13H13ClN2O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C(NC1=C(C)C=CC=C1Cl)=O)=C2N(C)C(=O)CS2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Carbamazepine

    Carbamazepine, a?sodium channel?blocker, is an anticonvulsant drug.

  • GX 201

    GX 201 is a selective NaV1.7 inhibitor, IC50 of < 3.2 nM for hNaV1.7.

  • ABBV-318

    ABBV-318 can be used as small molecule Nav1.7/Nav1.8 blockers for the treatment of pain, with IC50 values of 2.8 μM for hNav1.7 and 3.8 μM for hNav1.8. ABBV-318 can be used to study pain-related disorders.